Phase III Study of Vincristine Sulfate Liposome For Injection In Adults With Naïve Acute Lymphoblastic Leukemia
Clinical trial NCT02072785 · UNKNOWN
Trial details
- NCT number
- NCT02072785
- Sponsor
- Nanjing Luye Sike Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-01
- Primary completion
- 2017-02-01
- Enrollment
- 480
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.